In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes. (2026). Tikrit Journal of Pharmaceutical Sciences, 20(1), 51-66. https://doi.org/10.25130/tjphs.2026.20.1.6.51.66